O. O. Gordeeva, I. V. Kolyadina, L. G. Zhukova, I. P. Ganshina, G. V. Vyshinskaya, M. A. Kazantseva, . . . A. A. Meshcheryakov. (2020). Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II-III triple-negative breast cancer. ABV-press.
Chicago Style (17th ed.) CitationO. O. Gordeeva, et al. Efficacy and Safety of Cisplatin and Paclitaxel (PlaTax Regimen) in the Neoadjuvant Treatment of Patients with Stage II-III Triple-negative Breast Cancer. ABV-press, 2020.
MLA (9th ed.) CitationO. O. Gordeeva, et al. Efficacy and Safety of Cisplatin and Paclitaxel (PlaTax Regimen) in the Neoadjuvant Treatment of Patients with Stage II-III Triple-negative Breast Cancer. ABV-press, 2020.
Warning: These citations may not always be 100% accurate.